This study is currently not recruiting participants.

Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans

Investigating Long-Acting Versus Oral Investigational Medication for Alcohol Use Disorder

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

This study will help assess the efficacy, defined by time to relapse, of long-acting naltrexone use versus oral naltrexone. The study question is does long-acting injectable naltrexone increase time to relapse for patients with alcohol use disorder.

Detailed description of study

This study will help assess the efficacy, defined by time to relapse, of long-acting naltrexone use versus oral naltrexone. The study question is does long-acting injectable naltrexone increase time to relapse for patients with alcohol use disorder.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: alcohol use disorder
  • Age: 100 years or below
  • Gender: All

This study investigates the effectiveness of long-acting injectable naltrexone compared to oral naltrexone for individuals with alcohol use disorder. Alcohol use disorder is a condition where a person has difficulty controlling their drinking despite negative consequences. The study aims to determine if the long-acting form of the medication can extend the time before a person returns to drinking.

Participants in this study will receive either the long-acting injectable naltrexone or the oral form of the medication. The study will monitor the time it takes for participants to relapse, which means returning to drinking alcohol after a period of not drinking.

  • Who can participate: Eligibility criteria include adults aged 18 and older with a diagnosis of alcohol use disorder. Participants must be willing to abstain from alcohol during the study period.
  • Study details: Participants will be randomly assigned to receive either the long-acting injectable investigational medication or the oral investigational medication. A placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine, will not be used in this study.
Updated on 19 Feb 2024. Study ID: 1809536110

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team